The cost-effectiveness of immediate treatment, percutaneous biopsy and active surveillance for the diagnosis of the small solid renal mass: Evidence from a markov model

Journal of Urology

Volumn 187, Issue 1, 2012, Pages 39-43

  Heilbrun, Marta E ^a   Yu, Junhua ^b   Smith, Kenneth J ^c   Dechet, Christopher B ^a   Zagoria, Ronald J ^d   Roberts, Mark S ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b TOURO UNIVERSITY CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

carcinoma; cost benefit analysis; diagnosis; kidney; Markov chains; renal cell

Indexed keywords

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CASE REPORT; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION TREE; HIDDEN MARKOV MODEL; HUMAN; HUMAN TISSUE; INCIDENTAL FINDING; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MEDICAL FEE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SENSITIVITY ANALYSIS; TUMOR DIAGNOSIS; TUMOR VOLUME;

BIOPSY, NEEDLE; COST-BENEFIT ANALYSIS; HUMANS; KIDNEY NEOPLASMS; MALE; MARKOV CHAINS; MIDDLE AGED; POPULATION SURVEILLANCE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 83555176014     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.09.055     Document Type: Article

References (27)

1. A.C. Novick, S.A. Campbell, and A.S. Belldegrun Guideline for Management of the Clinical Stage 1 Renal Mass 2009 American Urological Association Education and Research Linthicum
2. A. Volpe, J.A. Cadeddu, and A. Cestari Contemporary management of small renal masses Eur Urol 60 2011 501
3. T. Klatte, J.J. Patard, and M. de Martino Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas J Urol 179 2008 1719
4. D.A. Kunkle, B.L. Egleston, and R.G. Uzzo Excise, ablate or observe: the small renal mass dilemmaa meta-analysis and review J Urol 179 2008 1227
5. L. Zini, P. Perrotte, and C. Jeldres A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses BJU Int 103 2009 899
6. J.M. Hollingsworth, D.C. Miller, and S. Daignault Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis Cancer 109 2007 1763
7. C.B. Dechet, H. Zincke, and T.J. Sebo Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults J Urol 169 2003 71
8. J.M. Hollingsworth, D.C. Miller, and S. Daignault Rising incidence of small renal masses: a need to reassess treatment effect J Natl Cancer Inst 98 2006 1331
9. A. Kutikov, B.L. Egleston, and Y.N. Wong Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram J Clin Oncol 28 2010 311
10. M. Remzi, E. Javadli, and M. Ozsoy Management of small renal masses: a review World J Urol 28 2010 275
11. I. Frank, M.L. Blute, and J.C. Cheville Solid renal tumors: an analysis of pathological features related to tumor size J Urol 170 2003 2217
12. B. Schlomer, R.S. Figenshau, and Y. Yan Pathological features of renal neoplasms classified by size and symptomatology J Urol 176 2006 1317
13. M.E. Heilbrun, R.J. Zagoria, and A.J. Garvin CT-guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablation AJR Am J Roentgenol 188 2007 1500
14. B.R. Lane, M.K. Samplaski, and B.R. Herts Renal mass biopsya renaissance? J Urol 179 2008 20
15. E. Arias United States Life Tables, 2006 2010 National Center for Health Statistics Hyattsville
16. H. Wunderlich, W. Hindermann, and A.M. Al Mustafa The accuracy of 250 fine needle biopsies of renal tumors J Urol 174 2005 44
17. R.M. Ness, A.M. Holmes, and R. Klein Utility valuations for outcome states of colorectal cancer Am J Gastroenterol 94 1999 1650
18. T.O. Tengs, and A. Wallace One thousand health-related quality-of-life estimates Med Care 38 2000 583
19. P.V. Pandharipande, D.A. Gervais, and P.R. Mueller Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis Radiology 248 2008 169
20. B. Shekarriz, J. Upadhyay, and H. Shekarriz Comparison of costs and complications of radical and partial nephrectomy for treatment of localized renal cell carcinoma Urology 59 2002 211
21. P.L. Crispen, R. Viterbo, and S.A. Boorjian Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance Cancer 115 2009 2844
22. L. Zini, J.J. Patard, and U. Capitanio Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma BJU Int 103 2009 894
23. S.N. Chawla, P.L. Crispen, and A.L. Hanlon The natural history of observed enhancing renal masses: meta-analysis and review of the world literature J Urol 175 2006 425
24. M. Aron, I.S. Gill, and S.A. Boorjian Treatment of the 2 to 3 cm renal mass J Urol 184 2010 419
25. P.V. Pandharipande, D.A. Gervais, and R.I. Hartman Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis Radiology 256 2010 836
26. S.L. Chang, L.E. Cipriano, and L.C. Harshman Cost-effectiveness analysis of nephron sparing options for the management of small renal masses J Urol 185 2011 1591
27. G. Novara, S. Secco, and M. Botteri Factors predicting health-related quality of life recovery in patients undergoing surgical treatment for renal tumors: prospective evaluation using the RAND SF-36 health survey Eur Urol 57 2010 112